Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BAY-293 |
Trade Name | |
Synonyms | BAY293|BAY 293 |
Drug Descriptions |
BAY-293 inhibits the interaction between Sos1 and Kras, leading to reduced Ras activation and downstream Erk phosphorylation, and potentially leading to decreased tumor cell proliferation (PMID: 30683722). |
DrugClasses | SOS1 Inhibitor 16 |
CAS Registry Number | 2244904-70-7 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Alvocidib + BAY-293 | Alvocidib BAY-293 | 0 | 0 |
ARS-853 + BAY-293 | ARS-853 BAY-293 | 0 | 0 |
BAY-293 | BAY-293 | 0 | 0 |
BAY-293 + Cisplatin | BAY-293 Cisplatin | 0 | 0 |
BAY-293 + Gefitinib | BAY-293 Gefitinib | 0 | 0 |
BAY-293 + Osimertinib | BAY-293 Osimertinib | 0 | 0 |
BAY-293 + Osimertinib + RMC-4550 | BAY-293 Osimertinib RMC-4550 | 0 | 0 |
BAY-293 + Palbociclib | BAY-293 Palbociclib | 0 | 0 |
BAY-293 + PD98059 | BAY-293 PD98059 | 0 | 0 |
BAY-293 + Pemetrexed Disodium | BAY-293 Pemetrexed Disodium | 0 | 0 |
BAY-293 + RMC-4550 | BAY-293 RMC-4550 | 0 | 0 |
BAY-293 + Sirolimus | BAY-293 Sirolimus | 0 | 0 |
BAY-293 + SN-38 | BAY-293 SN-38 | 0 | 0 |
BAY-293 + Trametinib | BAY-293 Trametinib | 0 | 0 |